Cardiopulmonary Complications of Hematopoietic Stem Cell Transplantation (HCT) and Gene Therapy Workshop
The NIH is hosting a hybrid workshop that dives into new research regarding the future of HCT and gene therapy for sickle cell disease.
The NIH is hosting a hybrid workshop that dives into new research regarding the future of HCT and gene therapy for sickle cell disease.
NIH will host the fourth public listening session aimed at gathering stakeholder input on efforts to modernize and enhance biosafety oversight.
Describes the meaning of participatory science, explores common ethical issues, and examines how these issues intersect with IRB review.